
See exactly how VGHAX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VGHAX and 80,000+ other tickers.
For over a quarter-century, this actively managed portfolio has offered investors an economical gateway to companies worldwide operating within the healthcare sector. Its holdings encompass pharmaceutical giants, medical equipment manufacturers, and cutting-edge research organizations. Compared to its peers in the healthcare space, this fund typically exhibits broader international exposure and a lower portfolio turnover rate. Nevertheless, investors should acknowledge the inherent concentration risk, as it exclusively targets the health care industry. Given that annual returns can fluctuate…
No recent news available.